About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

President Biden Signs “Ending Forced Arbitration of Sexual Assault and Sexual Harassment” Act into Law

On March 3, 2022, President Biden signed into law the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021, which restores survivors’ option to hold their abusers accountable in public court rather than in secretive, private arbitration (often funded by the defendant). The law prohibits employers from imposing the provisions of arbitration

2022-03-04T21:23:40+00:00March 4th, 2022|Employment Law|

WHO Releases Detailed Report on Negative Impacts of Aggressive Formula Milk Marketing on New Parents

The World Health Organization and UNICEF have published a new report that summarizes the findings of a multi-national study examining the impact of formula milk marketing on infant feeding decisions and practices. The research study, the largest of its kind to date, draws on the experiences of over 8,000 women and more than 300 health

Abbott Labs Expands Urgent Recall of Similac, Alimentum, EleCare After Second Infant Death

Potentially lethal bacteria feared to be present in Abbott’s powdered milk products aimed at infants Abbott Laboratories has expanded its nationwide emergency recall of three infant powdered milk products after a second infant has died after using the formula. Originally recalled on February 18, 2022, the formula variations were all produced at Abbott’s manufacturing facility

Thousands of U.S. communities to receive opioid recovery funds from $26 billion global settlements as soon as May 2022

Over 90% of litigating local governments have confirmed participation in the global settlements approved today by the “Big Three” drug distributors AmerisourceBergen, Cardinal Health, and McKesson, along with opioid manufacturer Johnson & Johnson Washington, D.C. (February 25, 2022) – Today, the National Prescription Opiate Litigation Plaintiffs’ Executive Committee confirmed participation of over 90% of litigating

2022-02-25T18:04:51+00:00February 25th, 2022|Mass Tort, Prescription Drug Injuries, Public Good|

Anne Shaver Pens Compelling Piece for Impact Fund: Ninth Circuit Finds Discrimination To Be Concrete Injury For Purposes Of Article III Standing

The following is from a piece published by the Impact Fund written by Lieff Cabraser partner Anne B. Shaver, explaining a recent Ninth Circuit decision to reject an attempt to insulate a bank from liability for admitted citizenship discrimination on standing grounds.

2023-04-19T19:24:44+00:00February 22nd, 2022|Discrimination, Firm News|

Jallé Dafa to Moderate ABA Section of Labor & Employment Law’s Black History Month Roundtable

Lieff Cabraser attorney Jallé Dafa will moderate the first of the ABA Labor & Employment Law Section’s Heritage Month Webinar Series on Thursday, February 24, 2022 at 12:00 pm CST. In recognition of Black History Month, the Section has assembled an extraordinary set of panelists for a roundtable conversation discussing their entries to the legal field, career

2022-02-23T01:48:01+00:00February 22nd, 2022|Firm News|

FDA Issues Urgent Recall on Infant Formulas Similac, Alimentum, and EleCare

Bulletin notes serious infant injuries and at least one infant death, warns of possible contamination at manufacturing plant as well as manufacturing problems On February 18, 2022, the U.S. Food and Drug Administration issued an urgent recall and warning relating to Abbott Nutrition Sturgis infant formula products Similac, Alimentum, and Elecare. The alarm arose in

2022-02-19T21:31:52+00:00February 19th, 2022|Infant & Child Injuries, Personal Injury|

Dean Harvey to be Featured Panelist at Berkeley Law’s 2022 Riesenfeld Symposium, “Big Money, Big Enforcement: New Frontiers in Global Antitrust Regulation”

Lieff Cabraser partner Dean M. Harvey will be a featured panelist at Berkeley Law’s 2022 Riesenfeld Symposium, Big Money, Big Enforcement: New Frontiers in Global Antitrust Regulation, to be held in-person on Tuesday, February 22, 2022. Dean will participate in a panel discussion on “Is Labor the Next Frontier of Antitrust?” where he will address the intersections between antitrust

2022-02-19T21:32:27+00:00February 16th, 2022|Firm News|